Invesco Ltd. Invests $9.24 Million in Alpha Teknova, Inc. (NASDAQ:TKNO)

Invesco Ltd. acquired a new stake in shares of Alpha Teknova, Inc. (NASDAQ:TKNO - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 1,106,161 shares of the company's stock, valued at approximately $9,236,000. Invesco Ltd. owned 2.07% of Alpha Teknova at the end of the most recent quarter.

Several other large investors have also made changes to their positions in TKNO. JPMorgan Chase & Co. lifted its position in Alpha Teknova by 622.5% during the fourth quarter. JPMorgan Chase & Co. now owns 4,400 shares of the company's stock valued at $37,000 after purchasing an additional 3,791 shares during the period. Mount Lucas Management LP acquired a new stake in Alpha Teknova during the fourth quarter worth about $75,000. China Universal Asset Management Co. Ltd. purchased a new position in Alpha Teknova during the fourth quarter valued at approximately $94,000. Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new position in Alpha Teknova in the fourth quarter valued at approximately $180,000. Finally, Whalen Wealth Management Inc. acquired a new position in Alpha Teknova in the fourth quarter valued at approximately $240,000. 13.81% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Craig Hallum started coverage on shares of Alpha Teknova in a report on Monday, February 10th. They set a "buy" rating and a $12.00 price target on the stock.

Alpha Teknova Price Performance

NASDAQ TKNO traded down $0.16 during trading hours on Friday, reaching $6.49. The company's stock had a trading volume of 199,097 shares, compared to its average volume of 359,081. The company's 50-day moving average is $5.85 and its two-hundred day moving average is $7.09. Alpha Teknova, Inc. has a 1-year low of $1.16 and a 1-year high of $10.37. The firm has a market capitalization of $346.81 million, a price-to-earnings ratio of -8.77 and a beta of 0.54. The company has a debt-to-equity ratio of 0.12, a current ratio of 4.73 and a quick ratio of 3.94.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last issued its quarterly earnings results on Tuesday, March 4th. The company reported ($0.11) EPS for the quarter. The firm had revenue of $9.27 million for the quarter, compared to analysts' expectations of $9.10 million. Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. On average, equities analysts predict that Alpha Teknova, Inc. will post -0.58 EPS for the current year.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.